Pharma major Dr Reddy’s Laboratories Ltd has launched Donepezil Hydrochloride Tablets, a therapeutic equivalent generic version of Aricept in the US market following the approval by the United States Food & Drug Administration (USFDA).

The drug is indicated in the treatment of dementia related to Alzheimer’s disease. The Aricept brand had US sales of approximately $92.6 million for the 12 months ending in May according to IMS Health, the Hyderabad-based company said in a release on Saturday.

Related Topics